Page 149 - Read Online

Page 10 of 10 Sobenin et al. Vessel Plus 2019;3:14 I http://dx.doi.org/10.20517/2574-1209.2018.63

28. Rossmanith W, Karwan RM. Impairment of tRNA processing by point mutations in mitochondrial tRNA(Leu) (UUR) associated with
mitochondrial diseases. FEBS Lett 1998;433:269-74.
29. Krag TO, Hauerslev S, Jeppesen TD, Duno M, Vissing J. Muscle regeneration in mitochondrial myopathies. Mitochondrion 2013;13:63-
70.
30. Valente L, Piga D, Lamantea E, Carrara F, Uziel G, et al. Identification of novel mutations in five patients with mitochondrial
encephalomyopathy. Biochim Biophys Acta 2009;1787:491-501.
31. Lim BC, Park JD, Hwang H, Kim KJ, Hwang YS, et al. Mutations in ND subunits of complex I are an important genetic cause of
childhood mitochondrial encephalopathies. J Child Neurol 2009;24:828-32.
32. Funalot B, Reynier P, Vighetto A, Ranoux D, Bonnefont JP, et al. Leigh-like encephalopathy complicating Leber's hereditary optic
neuropathy. Ann Neurol 2002;52:374-7.
33. Tarnopolsky MA, Baker SK, Myint T, Maxner CE, Robitaille J, et al Clinical variability in maternally inherited leber hereditary optic
neuropathy with the G14459A mutation. Am J Med Genet A 2004;124A:372-6.
34. Andreu AL, Bruno C, Dunne TC, Tanji K, Shanske S, et al. A nonsense mutation (G15059A) in the cytochrome b gene in a patient with
exercise intolerance and myoglobinuria. Ann Neurol 1999;45:127-30.
35. Mueller EE, Eder W, Ebner S, Schwaiger E, Santic D, et al. The mitochondrial T16189C polymorphism is associated with coronary
artery disease in Middle European populations. PLoS One 2011;6:e16455.
36. Gastaldi G, Giacobino JP, Ruiz J. Metabolic syndrome, a mitochondrial disease? Rev Med Suisse 2008;4:1387-8, 1390-1. (in French)
37. Indo HP, Davidson M, Yen HC, Suenaga S, Tomita K, et al. Evidence of ROS generation by mitochondria in cells with impaired
electron transport chain and mitochondrial DNA damage. Mitochondrion 2007;7:106-18.
38. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, et al. ROS-generating mitochondrial DNA mutations can regulate
tumor cell metastasis. Science 2008;320:661-4.
39. Maassen JA, 'T Hart LM, van Essen E, Heine RJ, Nijpels G, et al. Mitochondrial diabetes: molecular mechanisms and clinical
presentation. Diabetes 2004;53:S103-9.
40. Choksi KB, Boylston WH, Rabek JP, Widger WR, Papaconstantinou J. Oxidatively damaged proteins of heart mitochondrial electron
transport complexes. Biochim Biophys Acta 2004;1688:95-101.
41. Smith SC Jr. Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med 2007;120:S3-11.
42. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 2004;286:H1597-602.
43. Sorriento D, Pascale AV, Finelli R, Carillo AL, Annunziata R, et al. Targeting mitochondria as therapeutic strategy for metabolic
disorders. ScientificWorldJournal 2014;2014:604685.
44. Ho SS. Current status of carotid ultrasound in atherosclerosis. Quant Imaging Med Surg 2016;6:285-96.
45. Polak JF, Szklo M, Kronmal RA, Burke GL, Shea S, et al. The value of carotid artery plaque and intima-media thickness for incident
cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2013;2:e000087.
46. Stančáková A, Laakso M. Genetics of metabolic syndrome. Rev Endocr Metab Disord 2014;15:243-52.
47. Sobenin IA, Galitsyna EV, Grechko AV, Orekhov AN. Small dense and desialylated low density lipoprotein in diabetic patients. Vessel
Plus 2017;1:29-37.
48. Orekhov AN, Sobenin IA. Modified lipoproteins as biomarkers of atherosclerosis. Front Biosci (Landmark Ed) 2018;23:1422-44.